Nitroxolin Forte Mip Pharma Polska (Nitroxoline)

Nitroxoline acts by chelating essential metal ions like iron and magnesium, which are cofactors for bacterial enzymes. This chelation inhibits key metabolic pathways, disrupts DNA synthesis, and impairs bacterial respiration, resulting in bacteriostatic or bactericidal activity against susceptible uropathogens.

The dosage of Nitroxolin Forte is determined by the prescribing clinician based on the specific infection, patient age, renal function, and other clinical factors. Healthcare professionals set the appropriate strength, frequency, and duration of therapy according to current medical guidelines.

Safety data for nitroxoline in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To request Nitroxolin Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nitroxolin Forte (nitroxoline) belongs to the quinolone derivative class and offers a distinct mechanism of metal‑ion chelation. Compared with agents such as trimethoprim‑sulfamethoxazole or fosfomycin, nitroxoline may retain activity against some resistant strains, but clinicians consider local susceptibility patterns, patient tolerance, and safety profiles when selecting therapy.

Nitroxolin Forte tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability. Do not use if the packaging is damaged or the tablets appear discolored.

Nitroxolin Forte is taken orally, usually with a full glass of water. It can be taken with or without food, unless the prescriber advises otherwise. Patients should follow the dosing schedule provided by their healthcare professional and complete the full course of therapy even if symptoms improve.

Serious adverse events, although rare, include hepatic dysfunction (elevated liver enzymes or hepatitis), severe allergic reactions such as anaphylaxis, blood dyscrasias like neutropenia or agranulocytosis, and acute kidney injury. Patients should seek immediate medical attention if they experience signs of liver injury, severe rash, unexplained bruising, or reduced urine output.

Nitroxolin Forte should be avoided in individuals with known hypersensitivity to nitroxoline or other quinolone derivatives. It is also contraindicated in patients with severe renal or hepatic impairment unless dose adjustments are made under specialist supervision. Children and adolescents should only use the drug if specifically prescribed, and pregnant or breastfeeding women should use it only when clearly indicated.